BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9764794)

  • 1. Complete regression of AIDS-related Kaposi's sarcoma-associated human herpesvirus-8 during therapy with indinavir.
    Martinelli C; Zazzi M; Ambu S; Bartolozzi D; Corsi P; Leoncini F
    AIDS; 1998 Sep; 12(13):1717-9. PubMed ID: 9764794
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
    AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.
    Blum L; Pellet C; Agbalika F; Blanchard G; Morel P; Calvo F; Lebbé C
    AIDS; 1997 Nov; 11(13):1653-5. PubMed ID: 9365774
    [No Abstract]   [Full Text] [Related]  

  • 4. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
    Wit FW; Sol CJ; Renwick N; Roos MT; Pals ST; van Leeuwen R; Goudsmit J; Reiss P
    AIDS; 1998 Jan; 12(2):218-9. PubMed ID: 9468373
    [No Abstract]   [Full Text] [Related]  

  • 5. Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
    Torre-Cisneros J; Pozo F; Serrano R; Vidal E; Rivero A; Tenorio A
    AIDS; 2000 Sep; 14(14):2215-7. PubMed ID: 11061671
    [No Abstract]   [Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
    Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
    J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!).
    Flanigan TP; Campbell T; Harwell J; Kumarasamy N
    J Infect Dis; 2005 Feb; 191(3):321-3. PubMed ID: 15633089
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
    Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
    Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
    Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
    Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.
    Monini P; Sgadari C; Grosso MG; Bellino S; Di Biagio A; Toschi E; Bacigalupo I; Sabbatucci M; Cencioni G; Salvi E; Leone P; Ensoli B
    AIDS; 2009 Feb; 23(4):534-8. PubMed ID: 19169139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-seropositive individual with persistent human herpesvirus 8 infection for >11 years without development of Kaposi's sarcoma.
    Meng YX; Lam LL; Kite-Powell K; Stamey FR; Pau CP; Pellett PE; Spira TJ
    Clin Infect Dis; 2000 Jan; 30(1):221-2. PubMed ID: 10619767
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
    J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
    Chan DJ
    Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.
    Ueno T; Mitsuishi T; Kimura Y; Kato T; Hasegawa H; Katano H; Sata T; Kurane S; Kawana S
    Eur J Dermatol; 2007; 17(6):539-40. PubMed ID: 17951139
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-associated Kaposi's sarcoma.
    Seybold U; Mayr D; Degenhart C; Bogner JR
    Infection; 2008 Feb; 36(1):96-7. PubMed ID: 18231715
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
    Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
    Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
    J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.